Kalbe Farma
- Machine translation, like DeepL or Google Translate, is a useful starting point for translations, but translators must revise errors as necessary and confirm that the translation is accurate, rather than simply copy-pasting machine-translated text into the English Wikipedia.
- Do not translate text that appears unreliable or low-quality. If possible, verify the text with references provided in the foreign-language article.
- You must provide copyright attribution in the edit summary accompanying your translation by providing an interlanguage link to the source of your translation. A model attribution edit summary is
Content in this edit is translated from the existing Indonesian Wikipedia article at [[:id:Kalbe Farma]]; see its history for attribution.
- You may also add the template
{{Translated|id|Kalbe Farma}}
to the talk page. - For more guidance, see Wikipedia:Translation.
- Pharmaceuticals
- Healthcare
Bernadette Ruth Irawati Setiady (President)
- Bintang Toedjoe
- Kalbe Nutritionals
- Kalbe Genexine Biologics
- Innogene Kalbiotech
- Bifarma Adiluhung
- Kalbe International
- Innolab Sains Internasional
- Pharma Metric Labs
- Saka Farma Laboratories
- Dankos Farma
- Hexpharm Jaya Laboratories
- Hale International
- Finusolprima Farma Internasional
- Kalbe Milko Indonesia
- Enseval Putera
- Indogravure
- Kalbe Morinaga
- Kalbe Vision
PT Kalbe Farma Tbk, or simply known as Kalbe, is an Indonesian pharmaceutical, healthcare and nutrition company established in 1966.[1] The company has expanded by strategic acquisitions of pharmaceutical companies, becoming an integrated consumer health and nutrition enterprise. The Kalbe Group has brands in the prescription drugs, OTC drugs, energy drink and nutrition products, distribution arm that reaches over 1 million outlets. Notably, the company produces misoprostol (sold under the brand name of Invitec), a drug which is used to treat stomach ulcers but is also widely used in Indonesia as an illegal abortifacient (abortion-inducing substance).[2]
Company brands in healthcare and pharmaceutical segments include Promag, Mixagrip, Woods, Komix, Prenagen, Extra Joss and Fitbar.[citation needed]
Kalbe is the largest publicly listed pharmaceutical company in Southeast Asia with around US$5 billion in market capitalization and revenues of over Rp 15 trillion.
History
Kalbe Farma was founded on September 10, 1966, by 6 siblings, K.L. Tjoen, Theresia H. Setiady, Khouw Lip Swan, Khouw Lip Boen (Also Known As: Dr. Boenyamin Setiawan), Maria Karmila, and F. Bing Aryanto. Kalbe Farma first began operations in a house garage that was owned by the founders.
In May 2020, Kalbe Farma signed a Memorandum of Understanding with South Korean pharmaceuticals company Genexine Inc. to develop a vaccine for the new corona virus or COVID-19.[3]
References
- ^ "Our Story". Kalbe Malaysia. 2023-01-13. Retrieved 2024-06-24.
- ^ Grafton-Green, Patrick (1 October 2017). "Anti-abortion MP Jacob Rees-Mogg admits profits from abortion pills". Evening Standard. Retrieved 25 March 2020.
- ^ "Kalbe Farma and South Korea's Genexine to Start Human Trial for Covid-19 Vaccine". Jakarta Globe. Retrieved 2020-09-06.
- Company Presentation - Q3 - 2018
External links
- Official website